Daniel Kellner, MD
Urology · New Haven, CTNPI 1730106279
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $105,904 of the $122,445 with a category attached, or 86.5%. Boston Scientific accounts for 91.9% of it on its own, with 11 other manufacturers making up the rest. Among urology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 143 payments — averaging $856.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$113K
- Lumenis, Inc$5K
- Richard Wolf Medical Instruments Corp.$4K
- Procept Biorobotics Corporation$771
- Laborie Medical Technologies Corp.$129
- Teleflex LLC$110
- plus $323 from 6 others
What the payments were for
- Consulting fees$5,4504%
- Speaking & faculty fees$105,90486%
- Travel & lodging$6,9276%
- Food & beverage$4,1643%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 118 | $112,569 |
| Lumenis, Inc | 3 | $4,756 |
| Richard Wolf Medical Instruments Corp. | 6 | $3,787 |
| Procept Biorobotics Corporation | 5 | $771 |
| Laborie Medical Technologies Corp. | 1 | $129 |
| Teleflex LLC | 3 | $110 |
| Neotract Inc. | 1 | $96 |
| Olympus America Inc. | 1 | $81 |
| Coloplast | 2 | $47 |
| Merck | 1 | $45 |
| Antares Pharma, Inc. | 1 | $44 |
| Ambu Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL BPH$40,560
- Lumenis Pulse 120H$32,483
- AquaBeam Robotic System$742
- Moses 550 DFL$644
- Moses 550 D\F\L$226
How this compares
$122,445 in reported general payments places this provider in the 95th percentile of 156 urology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 154 | $109,643 |
| MyrbetriqMirabegron | 117 | $98,750 |
| Tamsulosin Hcl | 937 | $15,740 |
| Mirabegron ErMirabegron | 13 | $10,041 |
| Silodosin | 113 | $8,430 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 250 | $6,223 |
| Solifenacin Succinate | 76 | $5,581 |
| Finasteride | 376 | $4,770 |
| Tolterodine Tartrate ErTolterodine Tartrate | 27 | $3,406 |
| Methenamine Hippurate | 43 | $3,030 |
| Potassium Citrate ErPotassium Citrate | 15 | $2,990 |
| Trospium Chloride | 20 | $1,442 |
| Dutasteride | 65 | $1,432 |
| Tadalafil | 19 | $1,070 |
| Oxybutynin Chloride ErOxybutynin Chloride | 20 | $1,065 |
Paid to pharmacies, not to this prescriber.
Other urology in New Haven
- Preston SprenkleNew Haven$57K
- Stanton HonigNew Haven$40K
- Michael LeapmanNew Haven$21K
- Jason LeeNew Haven$19K
- Leslie RickeyNew Haven$17K
- Gregory LacyNew Haven$11K
- Fady GhaliNew Haven$10K
- Guy ManettiNew Haven$7K
- Wei Shen TanNew Haven$6K
- Ganesh SanekommuNew Haven$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.